Position in TNYA
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$9,757
New position
Shares Held
14,100
first reported quarter
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 103 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Private Advisor Group, LLC holds $54,115,412 across 44 Biotechnology names. TNYA ranks #43 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,315 | $13,378,261 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,648,556 | $12,644,424 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
106,662 | $5,073,911 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,433 | $3,765,671 | |
| 5 | CRMD |
CorMedix Inc.
|
504,668 | $3,426,695 | |
| 6 | TLX |
Telix Pharmaceuticals Ltd
|
174,415 | $1,669,151 | |
| 7 | AVXL |
Anavex Life Sciences Corp.
|
499,700 | $1,534,079 | |
| 8 | CDXS |
Codexis, Inc.
|
847,001 | $1,380,611 |
All Filings in TNYA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,757 | 14,100 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||